The CDSCO of India is the main regulatory body for the regulation of pharmaceutical and medical devices.

2.  CDSCO is regulatory body of India that regulate the pharmaceuticals ,
medical devices and clinical trails.
 Head office located in new Delhi and functioning under the control of
directorate general of health services ,ministry of health services govt of
India.
 DGCI [drugs controller general of India responsible for approval of new
drugs. And CDSCO is discharging functions under drugs and cosmetic act .
 DGCI is advised by the drug technical advisory board{DTAB}and drug
consultative committee {DCC}.
 Drug inspector appointed by the central and state government by section
21

3.  Approval of new drugs
 Importing registration and licensing
 Licensing of blood banks,LPVs,vaccines,r-DNA
 Amendments to D&C Act and rules
 Banning of drugs ang cosmetics
 Testing of drugs by central labs
 Monitoring adverse drug reaction
 guidance on technical matter

4. CDSCO
Head quarter Zonal office Sub zonal office laboratories
New Delhi
North :Ghaziabad
South: Chennai
East : Kolkata
West : Mumbai
1. Bangalore
2. Chandigarh
3. Jammu
4. Goa
CDL: Kausali
CDL: Kolkata
RDTL:Guwahathi
RDTL:Chandigarh
CDTL: Mumbai
CDTL: Chennai
New drugs
CLAA
GAMP
Audits
Testing of drug
samples

5.  Drug controller general of India
 Joint drug controller
 Assistant drug controller
 Drug inspector
 Assistant drug inspector
 Technical officer

6.  approval of new drugs and clinical trails
 Amendments to drugs and cosmetic rules
 Banning of drugs and cosmetics
 Grant technical license

7.  Laying standard of drugs ,cosmetics, diagnostic and devices
 To regulate the market authorization of new drugs
 To regulate standard of importing of drugs
 Testing of drugs by clinical labs
 Publication of Indian pharmacopeia

8.  approval of drug testing laboratories.
 Recall of substandard drugs.
 Licensing of establishment for sale or distribution of drugs.
 Investigation and prosecution in respect of contravention of legal
provision.

9.  Licensing of drugs manufacturing authority and sales establish ments
 Licensing of drugs testing laboratories
 approval of drugs formulation for manufacture.
 Pre and post licensing inspections.
 Recall of substandard drugs.